Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 5/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.55 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.53 |
| ▸ | ACE | P12821 | 1/20 | 0.52 |
| ▸ | CTSC | P53634 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2193237 | 0.96 | GHSR (0.61) | GHSRACECTSC | |
| SCHEMBL2182587 | 0.91 | CTSC (0.62) | ACECTSC | |
| SCHEMBL9057338 | 0.88 | KDM4E (0.55) | GHSROPRM1OPRD1CTSC | |
| SCHEMBL10750299 | 0.87 | CTSC (0.54) | GHSROPRM1OPRD1ACECTSC | |
| SCHEMBL29749345 | 0.86 | ACE (0.63) | GHSRACE | |
| SCHEMBL2195848 | 0.86 | GHSR (0.55) | GHSRACECTSC | |
| SCHEMBL1650522 | 0.85 | MMP2 (0.55) | GHSROPRM1OPRD1CTSC | |
| SCHEMBL29993798 | 0.85 | OPRD1 (0.65) | GHSROPRM1OPRD1ACE | |
| SCHEMBL30052433 | 0.85 | ACE (0.69) | GHSRACE | |
| SCHEMBL30052407 | 0.85 | ACE (0.69) | GHSRACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9173951-B2 | Carbohydrate-based drug delivery polymers and conjugates thereof | NEKTAR THERAPEUTICS (US) | 2015-11-03 | — | — | US | disclosed |
| US-20150051371-A1 | CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF | NEKTAR THERAPEUTICS (US) | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051371-A1 | CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF | STT3B, STT3A, DDOST | GHSR 1832/4885OPRM1 3352/4885OPRD1 3859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.